Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-01-23 @ 1:44 PM
Study NCT ID:
NCT01935934
Status:
COMPLETED
Last Update Posted:
2025-10-01
First Post:
2013-09-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-03
First Submit QC Date:
None
Study First Post Date:
2013-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-28
Results First Submit QC Date:
None
Results First Post Date:
2020-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-10-01
Last Update Post Date Type:
ESTIMATED